View of Claudin-6 (CLDN6) and Folate Receptor Alpha (FRα) Targeted Antibody-Drug Conjugates: Bypassing Platinum Resistance and Tumor Heterogeneity in High-Grade Serous Ovarian Carcinoma

Return to Article Details Claudin-6 (CLDN6) and Folate Receptor Alpha (FRα) Targeted Antibody-Drug Conjugates: Bypassing Platinum Resistance and Tumor Heterogeneity in High-Grade Serous Ovarian Carcinoma Download Download PDF